NP

Nilesh Pandharinath Chaudhari

Active Director Director DIN 10233617
DIN 10233617 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilesh Pandharinath Chaudhari

Data last updated:

Nilesh Pandharinath Chaudhari is a Director at Mediphyl Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10233617
Primary Designation Director
Industry Pharma
First Appointment 10 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jul 20232023Active

Board colleagues of Nilesh Pandharinath Chaudhari

Directorship timeline

Open interactive timeline →
Mediphyl Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Nilesh Pandharinath Chaudhari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Pandharinath Chaudhari

Nilesh Pandharinath Chaudhari currently holds 1 directorship: Mediphyl Pharmaceutical Private Limited (Director, since 10 Jul 2023).

Nilesh Pandharinath Chaudhari was first appointed on 10 Jul 2023 as Director at Mediphyl Pharmaceutical Private Limited.

The current boards of Nilesh Pandharinath Chaudhari's companies include Gaurav Manohar Pawar (Mediphyl Pharmaceutical Private Limited), Prasad Dilip Yeole (Mediphyl Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available